Literature DB >> 21333207

Robot-assisted excision of a retroperitoneal mass between the left renal artery and vein.

Todd Lehrfeld1, Rachel Natale, Saurabh Sharma, Pierre J Mendoza, Charles W Schwab Ii, David I Lee.   

Abstract

BACKGROUND: Extra-adrenal pheochromocytomas are rare. Minimally invasive techniques have been utilized for incidentally discovered masses with successful results.
METHODS: We present a case of a 64-year-old female with a 3.5-cm mass located between her left renal artery and vein, treated by a 4-port robot-assisted transperitoneal laparoscopic approach.
RESULTS: Careful dissection of the tumor away from the renal hilum was accomplished without major vascular injury. A pedicle to the tumor was identified and ligated. The pathology demonstrated a benign pheochromocytoma. To our knowledge, this is the first report of a peri-hilar excision of a pheochromocytoma using this approach.
CONCLUSION: Extra-adrenal pheochromocytomas are rare and can present in difficult locations. While surgical excision may be challenging, the da Vinci Robot may be used effectively and safely for the treatment of these perihilar masses.

Entities:  

Mesh:

Year:  2010        PMID: 21333207      PMCID: PMC3041050          DOI: 10.4293/108680810X12924466006927

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


INTRODUCTION

Extra-adrenal pheochromocytomas are rare tumors found in the general population. When discovered, they are usually within the Organ of Zuckerkandl, a conglomerate of neuroendocrine tissue located along the aorta. We present the management of a 64-year-old female with an extra-adrenal pheochromocytoma found in an unusual location between the left renal artery and vein.

CASE REPORT

The patient is a 64-year-old, white female with a recent history of cardiac catheterization who presented with a retroperitoneal mass located between her left renal artery and vein (. Her medical history includes mild hypertension controlled with amlodipine. Her recent cardiac stents necessitated daily aspirin and clopidogrel. The mass was diagnosed on an abdominal CT performed one year earlier for unexplained abdominal pain. The well-circumscribed mass was initially 2.0cm in diameter and enhanced with IV contrast administration. There was no lymphadenopathy noted. On serial CTs, the mass grew to a size of 3.5cm (. This prompted a percutaneous biopsy that was inconclusive but complicated by a retroperitoneal hematoma. Postbiopsy hypertension was not noted, and the patient did not require a blood transfusion. Due to the increasing size of the mass, however, a decision was made to perform an excisional biopsy of the mass using a robot-assisted laparoscopic approach. The patient exhibited none of the usual signs or symptoms of a pheochromocytoma. Contrast-enhanced CT in the axial plane, showing the mass at the left renal hilum.

Surgical Technique

No significant medical modifications were performed, because the patient had no stigmata of a pheochromocytoma. The procedure was performed with the patient in the right lateral decubitus position. A transperitoneal approach was used, and insufflation was obtained using a Veress needle technique. A 12-mm camera port was placed lateral to the rectus muscle at the level of the umbilicus. Two 8-mm robotic trocars were placed: one in the left lower quadrant above the anterior superior iliac spine and the other in the upper left quadrant midline between the xiphoid and the umbilicus, approximately 14cm apart. A 5-mm assistant port was placed midline just below the umbilicus. The left colon was mobilized medially. The gonadal vein was traced to the level of the renal vein where the mass was clearly visible. Careful dissection enabled excellent visualization of the gonadal, ascending lumbar, and adrenal vein branches of the left renal vein. The mass was trapped behind the left renal vein and invested by venous tributaries (. The gonadal vein was ligated and divided to create a window where the mass could be removed from behind the vein. Two other small veins were divided. During the dissection, one of these branches was avulsed from the main renal vein and repaired with a figure of eight 4-0 Prolene stitch. The mass was then mobilized from behind the vein. A small vascular pedicle was noted and clipped with titanium clips, and the mass was excised en bloc (. Hemostasis was ensured, and SugiFLO hemostatic matrix (Johnson & Johnson, Somerville, NJ) was applied to the surgical bed. The mass was placed into a laparoscopic entrapment sac and sent for pathologic examination. View of mass posterior to the left renal vein. A posterior lumbar vessel was encountered and controlled accordingly. The mass completely mobilized. The patient tolerated the procedure very well and had an uneventful postoperative course. She was discharged home on postoperative day one. Final surgical pathology demonstrated a 3.4x2.9x2.0-cm pheochromocytoma without evidence of malignancy.

DISCUSSION

Pheochromocytomas are rare tumors consisting of catecholamine-producing chromaffin cells usually arising from the adrenal medulla. In 15% to 25% of cases, they may arise from the embryological adrenal remnants referred to as extra-adrenal paragangliomas.[1-4] These are found approximately 4 times as often in children as in adults.[5] In adults, 85% of these occur in the abdomen,[6] mainly along the para-spinal sympathetic ganglion and organ of Zuckerkandl. Clinically, pheochromocytomas may occur along with hypertension, tachycardia, pallor, and headache.[4,7] Hypertension is classically paroxysmal, with or without sustained hypertension. Conversely, the patient may be normotensive without a history of hypertension, particularly in incidentalomas.[8] Given the exponential increase in imaging tests ordered in recent years, 25% of all discovered pheochromocytomas are incidental findings. The number of normotensive patients with pheochromocytomas has increased significantly as well.[8-11] While most pheochromocytomas occur sporadically, there is significant evidence of a genetic component, particularly within familial syndromes, such as von Hippel-Lindau, neurofibromatosis type 1, and multiple endocrine neoplasia 2A and 2B.[12] Recent advances in genetic analysis have demonstrated hereditary causes of paragangliomas as well, such as mutations in the enzyme succinate dehydrogenase.[13,14] There is growing interest in minimally invasive approaches for the treatment of small tumors discovered incidentally on imaging. Laparoscopic adrenalectomy has been reported for pheochromocytoma.[15] Because it is a much less common entity, significantly less data are available on such techniques for extra-adrenal disease. Given the difficult location of this mass, a robot-assisted laparoscopic approach was used. The minor vascular repair was performed without difficulty. This may have proven to be a challenge had a standard laparoscopic procedure been used. Our port configuration enabled easy access to the mass as well as the lower pole of the kidney. Additionally, the 3-dimensional vision afforded clear delineation of the vascular anatomy investing the tumor. The renal vein and all tributaries caused very little difficulty during the dissection. A consideration was made to excise this mass from a retroperitoneal approach. This may have potentially avoided the venous tributaries encountered during the dissection. However, the increased working room afforded by the transperitoneal approach proved to be both safe and efficacious.

CONCLUSION

This is to our knowledge the first reported case of a robot-assisted laparoscopic excision of a peri-hilar pheochromocytoma. The benefits of the da Vinci Surgical System including the wristed instrumentation and 3-dimensional vision were felt to be useful in the successful completion of this case without renal loss or conversion to open excision.
  15 in total

Review 1.  The clinically inapparent adrenal mass: update in diagnosis and management.

Authors:  Georg Mansmann; Joseph Lau; Ethan Balk; Michael Rothberg; Yukitaka Miyachi; Stefan R Bornstein
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

Review 2.  Extra-adrenal pheochromocytoma.

Authors:  R K Whalen; A F Althausen; G H Daniels
Journal:  J Urol       Date:  1992-01       Impact factor: 7.450

Review 3.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

4.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

Authors:  F Mantero; M Terzolo; G Arnaldi; G Osella; A M Masini; A Alì; M Giovagnetti; G Opocher; A Angeli
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

5.  Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients.

Authors:  D Erickson; Y C Kudva; M J Ebersold; G B Thompson; C S Grant; J A van Heerden; W F Young
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

6.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

Authors:  Hartmut P H Neumann; Christian Pawlu; Mariola Peczkowska; Birke Bausch; Sarah R McWhinney; Mihaela Muresan; Mary Buchta; Gerlind Franke; Joachim Klisch; Thorsten A Bley; Stefan Hoegerle; Carsten C Boedeker; Giuseppe Opocher; Jörg Schipper; Andrzej Januszewicz; Charis Eng
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

7.  Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

Authors:  Anne-Paule Gimenez-Roqueplo; Judith Favier; Pierre Rustin; Claudine Rieubland; Malvina Crespin; Valérie Nau; Philippe Khau Van Kien; Pierre Corvol; Pierre-François Plouin; Xavier Jeunemaitre
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients.

Authors:  Jean-Philippe Baguet; Laure Hammer; Tânia Longo Mazzuco; Olivier Chabre; Jean-Michel Mallion; Nathalie Sturm; Philippe Chaffanjon
Journal:  Eur J Endocrinol       Date:  2004-05       Impact factor: 6.664

Review 9.  Pheochromocytoma: the expanding genetic differential diagnosis.

Authors:  Jennifer Bryant; Jennifer Farmer; Lisa J Kessler; Raymond R Townsend; Katherine L Nathanson
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

10.  Advances in pheochromocytoma management in the era of laparoscopy.

Authors:  Eliney F Faria; Cassio Andreoni; Rodrigo K Krebs; Humberto Nascimento; Susan M Goldman; Claudio Kater; Valdemar Ortiz
Journal:  J Endourol       Date:  2007-11       Impact factor: 2.942

View more
  5 in total

1.  Incidental retroperitoneal paraganglioma in patient candidate to radical prostatectomy: Concurrent surgical treatments by robotic approach.

Authors:  Matteo Ferrari; Mattia Sangalli; Matteo Zanoni; Massimo Ghezzi; Fabio Fabbri; Francesco Sozzi; Patrizio Rigatti; Andrea Cestari
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Expanding the horizon of robotic surgery to large pelvic paraganglioma.

Authors:  Santosh Kumar; M Pragatheeswarane; Aditya Prakash Sharma; Kshitij Bishnoi; Manjeet Kumar Sharma; Vikas Kumar Panwar; Sameer Sethi
Journal:  J Robot Surg       Date:  2016-11-03

3.  Robot-assisted resection of a retrocaval peridiaphragmatic mass.

Authors:  Younghoon Roh; Mario Masrur; Pier Cristoforo Giulianotti
Journal:  JSLS       Date:  2014 Jan-Mar       Impact factor: 2.172

4.  Preliminary experience of the robot-assisted laparoscopic excision of a retroperitoneal mass: A case report.

Authors:  Qin Liu; Xinjing Wang; Baiyong Shen; Liangchao Zhao; Qian Zhan; Shulin Zhao; Chenlei Wen; Xiaxing Deng; Chenghong Peng; Hongwei Li
Journal:  Oncol Lett       Date:  2014-09-12       Impact factor: 2.967

5.  Surgical treatment of a retroperitoneal benign tumor surrounding important blood vessels by fractionated resection: A case report and review of the literature.

Authors:  Zhili Wan; Tiansheng Yin; Hongwei Chen; Dewei Li
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.